Canada Europe Germany UK France Italy Spain Netherlands Asia Pacific China Japan India Australia South Korea Latin America Brazil Mexico Argentina Middle East and Africa South Africa Saudi Arabia UAE Table of Contents Chapter 1 Methodology and Scope Chapter 2 Executive Summary Chapter 3 Industry Insights Chapter 4 Competitive Landscape, 2024 Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn) Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn) Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn) Chapter 8 Market Estimates and Forecast, By Manufacturer Type, 2021 - 2034 ($ Mn) Chapter 9 Market Estimates and Forecast, By Synthesis Technology, 2021 - 2034 ($ Mn) Chapter 10 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn) Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn) Chapter 12 Company Profiles Don't see your key competitors
[15] For tirzepatide specifically, cardiovascular outcome trial data are still emerging, and the UK SmPC does not currently include a cardiovascular risk reduction claim
Broadcom itself is down almost 6% over the past month, which drags on a market-cap-weighted fund with 5%+ in it
Igarashi T, Kohara A, Shikata Y, Sagami F, Sonoda J, Horie T, et al
